100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.2 TrustPilot
logo-home
Exam (elaborations)

CURRENT Medical Diagnosis & Treatment 2026 (65th Ed.) Test Bank – Internal Medicine MCQs with Rationales | CMDT 2026 Exam Prep

Rating
-
Sold
-
Pages
690
Grade
A+
Uploaded on
05-11-2025
Written in
2025/2026

CURRENT Medical Diagnosis & Treatment 2026 (65th Ed.) Test Bank – Internal Medicine MCQs with Rationales | CMDT 2026 Exam Prep Description: Master clinical reasoning and diagnostic precision with the CURRENT Medical Diagnosis and Treatment 2026 (65th Edition) Test Bank, the most comprehensive Internal Medicine MCQ resource for academic and board exam success. Designed for medical, nursing, and allied health learners preparing for the NCLEX-RN, HESI, USMLE Step exams, and internal medicine clerkships, this digital test bank transforms textbook knowledge into applied clinical mastery. Developed from the authoritative CMDT 2026 by Papadakis, Rabow, McQuaid, Nadler, and Price, this all-inclusive test bank delivers full-textbook coverage—every chapter, every system, every major condition—through 20 evidence-based multiple-choice questions per chapter, each paired with detailed, CURRENT-referenced rationales that strengthen your understanding of pathophysiology, diagnosis, and management. Key Features: Full coverage of CURRENT Medical Diagnosis & Treatment 2026 (65th Ed.) 20 expertly written clinical MCQs per chapter (hundreds of total questions) Correct answers with step-by-step, evidence-based rationales Integrates pathophysiology, clinical judgment, and diagnostic reasoning Aligned with NCLEX-RN, HESI, USMLE, and internal medicine exam blueprints Developed by internal medicine and nursing education experts Ideal for med students, nurses, residents, and faculty Boosts confidence, accuracy, and exam performance Elevate your study efficiency with the CMDT 2026 Test Bank—the gold-standard learning tool trusted by educators and clinicians worldwide. Keywords: CMDT 2026 test bank CURRENT Medical Diagnosis and Treatment 2026 internal medicine MCQs medical test bank 2026 Papadakis CMDT 65th edition HESI internal medicine prep NCLEX-RN CMDT review USMLE internal medicine questions Hashtags: #InternalMedicine #TestBank #MedicalEducation #CMDT2026 #NCLEXPrep #HESIReview #USMLEStudy #ClinicalReasoning #MedStudentResources #EvidenceBasedLearning

Show more Read less
Institution
NCLEX RN
Course
NCLEX RN











Whoops! We can’t load your doc right now. Try again or contact support.

Written for

Institution
NCLEX RN
Course
NCLEX RN

Document information

Uploaded on
November 5, 2025
Number of pages
690
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

Content preview

CURRENT Medical Diagnosis and
Treatment 2026
65th Edition


Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price


TEST BANK
1)
Reference: Ch. — Disease Prevention & Health Promotion —
Immunizations & Adult Preventive Care
Question Stem: A 68-year-old man with well-controlled type 2
diabetes asks which vaccines are most important this season to
reduce his risk of serious respiratory infection. Which
immunization should you prioritize?
Options:
A. Live attenuated influenza vaccine (LAIV) intranasal
formulation
B. High-dose inactivated influenza vaccine (intramuscular)

,C. PPSV23 (pneumococcal polysaccharide) only
D. HPV vaccine series initiation now
Correct Answer: B
Rationales:
• Correct (B): High-dose inactivated influenza vaccine is
recommended for adults ≥65 years to improve
immunogenicity and reduce influenza-related morbidity
and hospitalization in older adults with chronic disease.
• Incorrect (A): LAIV is contraindicated in older adults (≥50–
65 depending on guidance) and in many adults with
chronic conditions.
• Incorrect (C): Pneumococcal vaccination is important, but
for immediate seasonal respiratory risk in this age group
influenza vaccine takes priority; pneumococcal strategy
often includes PCV followed by PPSV23 per schedule.
• Incorrect (D): HPV vaccination is not routinely indicated to
initiate at age 68; benefit in this age group is minimal.
Teaching Point: High-dose inactivated influenza vaccine is
preferred for older adults to reduce severe influenza outcomes.
Citation: Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. Disease Prevention & Health
Promotion.

,2)
Reference: Ch. — Disease Prevention & Health Promotion —
Cancer Screening Principles
Question Stem: A 55-year-old woman with average cancer risk
asks whether to continue routine screening. According to
evidence-based screening principles, which screening should be
continued at this age?
Options:
A. Annual pelvic exam with Pap smear only (no HPV testing)
B. Colon cancer screening with colonoscopy every 10 years if
prior test normal
C. Mammography discontinued after age 50 for all women
D. CA-125 measurement annually for ovarian cancer screening
Correct Answer: B
Rationales:
• Correct (B): Average-risk adults starting at recommended
ages should continue colorectal cancer screening;
colonoscopy every 10 years is an accepted option if prior
tests were normal.
• Incorrect (A): Pap/HPV screening intervals vary; annual
Pap alone is not recommended for average-risk women—
co-testing and extended intervals are used.
• Incorrect (C): Mammography recommendations vary, but
many guidelines continue screening past 50; blanket
discontinuation at 50 is incorrect.

, • Incorrect (D): CA-125 is not recommended for routine
ovarian cancer screening in asymptomatic average-risk
women.
Teaching Point: Continue recommended colorectal screening
(e.g., colonoscopy every 10 years) in average-risk adults.
Citation: Papadakis et al. (2026). CURRENT Medical Diagnosis &
Treatment 2026 (65th Ed.). Ch. Disease Prevention & Health
Promotion.


3)
Reference: Ch. — Disease Prevention & Health Promotion —
Tobacco Cessation & Behavioral Interventions
Question Stem: A 45-year-old smoker (30 pack-years) wants to
quit. Which first-line pharmacotherapy paired with counseling
offers the best evidence for enhancing cessation success?
Options:
A. Bupropion SR plus behavioral counseling
B. Low-dose benzodiazepine for stress plus counseling
C. Nicotine lozenges alone without counseling
D. Varenicline avoided; recommend hypnosis only
Correct Answer: A
Rationales:
• Correct (A): Bupropion SR combined with behavioral
counseling is evidence-based first-line therapy that
increases quit rates and is appropriate for many smokers.
$27.49
Get access to the full document:

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

Get to know the seller
Seller avatar
jameskiokokyule

Get to know the seller

Seller avatar
jameskiokokyule Princeton
View profile
Follow You need to be logged in order to follow users or courses
Sold
2
Member since
6 months
Number of followers
0
Documents
123
Last sold
3 weeks ago

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions